Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO9B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | HCCS | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RPL12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | FBLN7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF234 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DARS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | FADS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ARMC5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | KCNK16 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZNF540 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |